FAKTOR OPTIONSSCHEIN - MERCK & CO. | Delayed Deutsche Boerse AG 11:01:02 28/06/2024 pm IST | ||
| 3.01 EUR | +0.33% |
|
| Current month | -9.09% | ||
| 1 month | +1.35% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 3.01 | +0.33% |
| 27/24/27 | 3 | +8.30% |
| 26/24/26 | 2.77 | +1.47% |
| 25/24/25 | 2.73 | -1.80% |
| 24/24/24 | 2.78 | -5.76% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 11:01 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | UBS |
| WKN | UL4DYA |
| ISIN | DE000UL4DYA6 |
| Date issued | 17/04/2023 |
| Strike | 173.1 $ |
| Maturity | Unlimited |
| Parity | 13.67 : 1 |
| Emission price | 5 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.51 € |
|---|---|
| Lowest since issue | 2.65 € |
| Spread | 0.03 € |
| Spread % | 0.98% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.8
USD
Average target price
142.7
USD
Spread / Average Target
+9.91%
- Stock Market
- Certificates
- Certificat
